Keenova Therapeutics plc presented clinical data from its Phase 2 plantar fibromatosis study at the American College of Foot and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE